In order to overcome these problems, our group has recently unrevealed a novel tumour specific target, represented by the hERG1/β1 integrin complex and developed a tool, in the format of a single chain diabody (scDb-hERG1/β1), able to target this macromolecular complex [33]. Here, KCNH2 is linked to neoplasm.